Cargando…
P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428381/ http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de |
_version_ | 1785090455400087552 |
---|---|
author | Oikonomou, Athanasios Valsecchi, Luigia Quadri, Manuel Watrin, Titus Scharov, Katerina Tu, Jia-Wey Bhatia, Sanil Bardini, Michela Fazio, Grazia Borkhardt, Arndt Palmi, Chiara Cazzaniga, Giovanni |
author_facet | Oikonomou, Athanasios Valsecchi, Luigia Quadri, Manuel Watrin, Titus Scharov, Katerina Tu, Jia-Wey Bhatia, Sanil Bardini, Michela Fazio, Grazia Borkhardt, Arndt Palmi, Chiara Cazzaniga, Giovanni |
author_sort | Oikonomou, Athanasios |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428381 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104283812023-08-17 P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA Oikonomou, Athanasios Valsecchi, Luigia Quadri, Manuel Watrin, Titus Scharov, Katerina Tu, Jia-Wey Bhatia, Sanil Bardini, Michela Fazio, Grazia Borkhardt, Arndt Palmi, Chiara Cazzaniga, Giovanni Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428381/ http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Oikonomou, Athanasios Valsecchi, Luigia Quadri, Manuel Watrin, Titus Scharov, Katerina Tu, Jia-Wey Bhatia, Sanil Bardini, Michela Fazio, Grazia Borkhardt, Arndt Palmi, Chiara Cazzaniga, Giovanni P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title | P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title_full | P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title_fullStr | P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title_full_unstemmed | P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title_short | P325: APPLICATIONS OF HIGH-THROUGHPUT DRUG SCREENING AS DRUG REPURPOSING STRATEGY FOR POOR OUTCOME SUBGROUPS OF PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
title_sort | p325: applications of high-throughput drug screening as drug repurposing strategy for poor outcome subgroups of pediatric b-cell precursor acute lymphoblastic leukemia |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428381/ http://dx.doi.org/10.1097/01.HS9.0000968212.76470.de |
work_keys_str_mv | AT oikonomouathanasios p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT valsecchiluigia p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT quadrimanuel p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT watrintitus p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT scharovkaterina p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT tujiawey p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT bhatiasanil p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT bardinimichela p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT faziograzia p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT borkhardtarndt p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT palmichiara p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia AT cazzanigagiovanni p325applicationsofhighthroughputdrugscreeningasdrugrepurposingstrategyforpooroutcomesubgroupsofpediatricbcellprecursoracutelymphoblasticleukemia |